Annan naturvetenskaplig och teknisk forskning och utveckling SNI 72109
I branschen Annan naturvetenskaplig och teknisk forskning och utveckling finns 1 360 aktiebolag med årsredovisningsdata. Visar plats 501–600, sorterade på omsättning.
1 360
aktiebolag
6376.2 M
kr i samlad omsättning
2 454
anställda
10.6%
median rörelsemarginal
Bolag — plats 501–600 efter omsättning
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 501 | FLUXER Aktiebolag | 428.6 k | 328.0 k | 76.5% | 1 |
| 502 | MEDISERA AKTIEBOLAG | 421.1 k | 262.0 k | 62.2% | — |
| 503 | SVEIND AB | 421.1 k | -237.4 k | -56.4% | — |
| 504 | Mattias Lorentzon Medicinkonsult AB | 420.7 k | 343.8 k | 81.5% | — |
| 505 | Malin Hultqvist Konsult AB | 420.6 k | 398.5 k | 94.7% | — |
| 506 | HN Life Science Consulting AB | 419.8 k | 103.4 k | 24.6% | 1 |
| 507 | Inference Labs AB | 418.3 k | -1.4 M | -165.3% | 1 |
| 508 | Soccermatics AB | 417.7 k | 408.5 k | 80.8% | 1 |
| 509 | Drax AB | 417.6 k | -713.6 k | -170.9% | 1 |
| 510 | Coldbay Innovation AB | 413.4 k | 349.5 k | 84.5% | 0 |
| 511 | L&L Sciences AB | 413.4 k | 404.6 k | 97.9% | — |
| 512 | Kibekon AB | 407.7 k | 320.9 k | 78.7% | — |
| 513 | Zatisfied Health AB | 400.3 k | -125.9 k | -31.4% | — |
| 514 | United Science & Capital Sweden AB | 400.0 k | 9.7 k | 0.2% | 1 |
| 515 | Lignidea Consulting AB | 398.4 k | 121.6 k | 30.5% | 1 |
| 516 | ALFA EXX AKTIEBOLAG | 389.9 k | 151.8 k | 38.9% | 1 |
| 517 | ZnOrdic AB | 389.2 k | 332.3 k | 85.4% | — |
| 518 | Gebart Energy AB | 385.3 k | 346.7 k | 90.0% | 1 |
| 519 | JAndlin Consulting AB | 383.0 k | 75.4 k | 19.7% | 1 |
| 520 | Thylabisco AB | 380.7 k | -81.2 k | -21.3% | — |
| 521 | Capice ADMET Consulting AB | 373.1 k | 153.6 k | 41.2% | — |
| 522 | EpiLys AB | 371.9 k | 335.2 k | 90.1% | 0 |
| 523 | Saltoria AB | 371.8 k | 122.6 k | 28.1% | 1 |
| 524 | ARTESIA GRUNDVATTENKONSULT AKTIEBOLAG | 371.6 k | -357.8 k | -96.3% | 2 |
| 525 | Synergos Nutrition AB | 370.0 k | 4.6 k | 1.3% | — |
| 526 | ENJ COLAB Aktiebolag | 367.2 k | 285.9 k | 77.9% | — |
| 527 | SWEPHARM AB | 361.0 k | -453.6 k | -113.6% | 1 |
| 528 | IGNITUS AKTIEBOLAG | 360.6 k | 109.9 k | 30.5% | 0 |
| 529 | ImmunoWise AB | 360.0 k | -1.2 M | -341.0% | — |
| 530 | Dioclea Labs AB | 357.2 k | -52.6 k | -14.7% | 3 |
| 531 | BIODAN AB | 348.3 k | -102.7 k | -29.5% | — |
| 532 | INSPECTRA ANALYS AKTIEBOLAG | 344.8 k | -367.9 k | -106.7% | 2 |
| 533 | Antonsson Clinical Research AB | 344.1 k | 288.8 k | 83.9% | 0 |
| 534 | Arnsvik-Malmberg Konsult AB | 340.8 k | 135.4 k | 39.7% | 1 |
| 535 | TeraSi AB | 339.0 k | -10.6 M | -115.8% | 11 |
| 536 | Molssonbirgersson AB | 337.5 k | 299.6 k | 88.8% | 1 |
| 537 | Genuinova AB | 336.4 k | 191.7 k | 57.0% | 1 |
| 538 | RML Consulting AB | 334.1 k | 265.5 k | 79.5% | 1 |
| 539 | Permadrive AB | 333.0 k | 133.1 k | 40.0% | 0 |
| 540 | ROLF BENNHAGEN AB | 332.2 k | 204.8 k | 59.8% | 1 |
| 541 | Slutplattan SIPZO 126194 AB | 331.4 k | -129.0 k | -38.9% | 1 |
| 542 | FractureFlowDynamics AB | 331.3 k | 294.3 k | 88.8% | — |
| 543 | Clartech AB | 327.6 k | -155.0 k | -47.3% | 1 |
| 544 | CME Consulting AB | 325.3 k | 298.9 k | 91.9% | — |
| 545 | APERIO AB | 323.6 k | -2.7 k | -0.8% | 1 |
| 546 | QAS Quantum Alloy Solver AB | 320.0 k | 243.2 k | 76.0% | 1 |
| 547 | Aquabiota water research ABWR AB | 317.7 k | -61.5 k | -19.4% | 0 |
| 548 | DanPET AB | 317.4 k | -460.9 k | -144.9% | 1 |
| 549 | MICROBUS I LJUNGBY AKTIEBOLAG | 315.0 k | 2.2 k | 0.7% | — |
| 550 | Xzencis AB | 313.9 k | -1.0 M | -319.5% | 1 |
| 551 | matomatic AB | 312.6 k | 89.4 k | 28.6% | 1 |
| 552 | Canto di Lacrime AB | 311.9 k | 219.7 k | 70.4% | — |
| 553 | Mattsson-Carlgren Consulting AB | 311.5 k | 302.3 k | 97.0% | — |
| 554 | Tomas Ekvall Research, Review & Assessment AB | 311.1 k | 5.7 k | 0.7% | — |
| 555 | Ferritico AB | 310.0 k | 1.4 M | 34.0% | 3 |
| 556 | ASTUDILLO MEDICAL AKTIEBOLAG | 309.5 k | 65.3 k | 21.1% | 1 |
| 557 | AddScience Sweden AB | 308.0 k | 32.4 k | 7.2% | — |
| 558 | TRAFFIC SAFETY RESEARCH AND ENGINEERING, TSRE AB | 303.9 k | 83.2 k | 27.4% | 2 |
| 559 | INERTIA AB | 303.1 k | -176.4 k | -39.4% | 2 |
| 560 | Förbränning och Fossila och Biobränslen i Göteborg AB | 300.0 k | 18.0 k | 6.0% | — |
| 561 | Calda AI AB | 300.0 k | -103.3 k | -34.4% | 2 |
| 562 | AB Alving C & C | 299.2 k | 230.5 k | 77.0% | — |
| 563 | DOCMAN AB | 296.1 k | -269.2 k | -90.9% | 1 |
| 564 | Medmatch AB | 295.5 k | -508.1 k | -147.3% | 1 |
| 565 | IgY Lab Systems AB | 289.5 k | 262.8 k | 90.8% | — |
| 566 | NewGenRef AB | 287.5 k | 235.3 k | 81.8% | — |
| 567 | Phase Space Computing AB | 286.8 k | 210.4 k | 73.4% | — |
| 568 | Enzo Piccolo AB | 285.1 k | 182.0 k | 63.8% | 0 |
| 569 | Anneli Andersson Consulting AB | 284.5 k | 203.4 k | 71.5% | 0 |
| 570 | Mäteria Technologies AB | 284.2 k | -17.9 k | -6.3% | 1 |
| 571 | Niconexus Consulting AB | 282.8 k | 262.7 k | 92.9% | — |
| 572 | BINTEC PROTOTYPER AB | 282.7 k | 61.5 k | 21.8% | — |
| 573 | Simplidoc AB | 280.8 k | -55.1 k | -19.6% | 0 |
| 574 | LungFlex AB | 278.0 k | -1.7 M | -622.3% | 0 |
| 575 | Neurometa Therapeutics AB | 274.8 k | -15.1 k | -5.5% | 1 |
| 576 | SAVEGGY AB | 273.5 k | -1.8 M | -9.2% | 7 |
| 577 | Simonsson Science AB | 271.6 k | -89.1 k | -32.8% | 1 |
| 578 | Mirasol LifeScience Consulting AB | 271.0 k | 78.3 k | 28.9% | 1 |
| 579 | P3S - Patient Safety Surveillance Solutions AB | 270.0 k | -13.5 k | -4.8% | 1 |
| 580 | VIKING MEDICIN AB | 270.0 k | 59.4 k | 22.0% | — |
| 581 | Bradley Konsult AB | 268.1 k | -19.5 k | -7.3% | 1 |
| 582 | Anders Rosengren Consulting AB | 264.9 k | 241.8 k | 91.3% | — |
| 583 | Ingemar Starke Consulting AB | 264.8 k | 254.5 k | 96.1% | — |
| 584 | Epigenica AB | 259.6 k | -15.8 M | -788.3% | 8 |
| 585 | Jallow Consulting AB | 257.0 k | 248.7 k | 96.8% | — |
| 586 | Spectoral AB | 256.8 k | 199.6 k | 77.7% | — |
| 587 | HeedBerget AB | 256.7 k | -143.1 k | -55.8% | — |
| 588 | ABENUM AKTIEBOLAG | 253.4 k | -16.3 k | -6.4% | 1 |
| 589 | SEMAIR DIAGNOSTICS AKTIEBOLAG | 252.9 k | -1.2 k | -0.5% | 2 |
| 590 | VETOK AKTIEBOLAG | 250.4 k | 183.2 k | 73.1% | — |
| 591 | Aurskall Akustik AB | 250.4 k | 182.1 k | 72.7% | 1 |
| 592 | Konsult Mikael Frisk AB | 242.7 k | 124.5 k | 51.3% | 1 |
| 593 | STB MED Aktiebolag | 240.0 k | 205.1 k | 85.5% | 0 |
| 594 | Biopromic AB | 239.8 k | 127.6 k | 53.2% | 0 |
| 595 | ADMEYT AB | 239.1 k | -67.8 k | -28.4% | 1 |
| 596 | Lynxalo AB | 238.8 k | 233.0 k | 97.6% | 1 |
| 597 | CBD Solutions AB | 238.5 k | -37.5 k | -15.7% | — |
| 598 | CLINICAL GENE NETWORKS AB | 237.4 k | -1.2 M | -430.1% | — |
| 599 | Cordiem AB | 235.6 k | 118.7 k | 50.4% | — |
| 600 | Magnephy AB | 234.0 k | 226.6 k | 43.7% | 1 |
501–600 av 1 360 bolag · sida 6 av 14